Scholz: EU recovery plan talks could take a while - Breaking The News

Scholz: EU recovery plan talks could take a while

10 July

1 min read

EPA-EFE/MICHELE TANTUSSI

Talks between European Union member states on the bloc's €750 billion coronavirus recovery fund may take longer than usual, German Finance Minister Olaf Scholz said on Friday.

However, Scholz expressed hope that a compromise would be reached and that funds would be available quickly.

Earlier, Scholz commented that he thinks Germany could be out of the coronavirus economic crisis by the beginning of 2022.

scholz coronavirus

Sycamore to take Walgreens private in up to $24B deal

6 March

Walgreens Boots Alliance has reached a deal worth up to $23.7 billion with private equity group Sycamore Partners that will bring the pharmacy chain's nearly 100-year run as a publicly traded company to an end.Sycamore will pay $11.45 per share in cash for Walgreens. Shareholders could also receive up to $3 more per share in the future from sales of Walgreens' primary-care businesses, including Village Medical, Summit Health and CityMD.Including debt...

Walgreens allegedly closing in on $10B deal to go private

4 March

Walgreens Boots Alliance Inc. is supposedly nearing a deal with private equity firm Sycamore Partners to go private for around $10 billion, the Wall Street Journal reported, citing people familiar with the matter. The two sides are aiming to finish up a deal as soon as Thursday and have been talking about Sycamore paying between $11.30 a share and $11.40 a share in cash, the unnamed sources said. If Sycamore completes the deal for the whole company,...

Roche's 2024 sales up 7% to 60.5B Swiss francs

30 January

F. Hoffmann-La Roche AG said on Thursday its annual sales in 2024 reached 60.5 billion Swiss francs, climbing 3% in Swiss francs and 7% at constant exchange rates (CER) from the same period a year earlier. Sales in the pharmaceuticals division grew 8% at CER to 46.2 billion Swiss francs, while diagnostics division sales rose 4% at CER year on year to 14.3 billion Swiss francs.In the year, net income dropped 19% at CER to 9.2 billion Swiss francs...

Purdue Pharma owners to pay up to $7.4B in opioid settlement

23 January

New York Attorney General Letitia James announced on Thursday that the Sackler family members, who own the OxyContin maker Purdue Pharma, reached a settlement to pay up to $7.4 billion "for their instrumental role in creating the opioid crisis."According to the new settlement, the Purdue Pharma owners will contribute up to $7.4 billion over the span of 15 years, with a portion of the money going to the victims of the opioid crisis. The first payment of $1.5...

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.